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 In 2005, Jayasinghe et al. began investigations into both elec-
trospraying and electrospinning of immortalized cell lines. [ 10–12 ] 
Despite the high voltages involved, these cells were surprisingly 
found to be viable post-electrospraying/electrospinning; this is 
due to both these techniques exploring high voltage DC supplies, 
while applying very low currents (generally in the nA range). [ 4,6 ] 
Subsequent work has extended these studies to a wide repertoire 
of different cell types, both murine and human, immortalized or 
primary, stem cells, and even whole fertilized embryos from model 
organisms. [ 13–18 ] Well-established protocols (such as fl ow cytom-
etry, genetic/genomic interrogation, and microarray analysis) 
demonstrated that cells processed using either electrospraying 
or electrospinning were indistinguishable from controls. Hence 
these technologies, now widely referred to as bio-electrospraying 
(BES) and cell electrospinning (CE), have become platform tech-
nologies for the biological and life sciences, and are undoubtedly 
the leading technologies for the direct handling of cells—both for 
distribution of cells with pinpoint precision as cell-bearing drop-
lets, and for the formation of truly 3D living scaffolds. 
 Many previous studies, including our own, have been car-
ried out with processed cells suspended in matrices generated 
from animal/tumor-derived materials, which contain largely 
uncharacterized growth factors and bioactive signals. [ 19 ] This 
makes them highly undesirable for clinical assays. While not 
applicable to humans, they have given confi dence to pursue 
this technology with advanced biopolymers, which could be 
directly translated to humans, thus ensuring the potential for 
creating artifi cial constructs which could be used for a variety 
of applications in the regenerative medicine fi eld. The present 
study describes the in vivo application of such biopolymers, 
using murine macrophages to interrogate biocompatibility and 
cellular behavior post-transfer. 
 Bio-electrospraying was carried out at various applied voltages 
to fl ow rates for the given electrode setup. A wide operational 
space was investigated to identify which operational conditions 
gave the most stable BES conditions. During these studies the 
selected hydrogels studied in these investigations were found 
to only be able to form jets, which subsequently underwent jet 
breakup to form charged cell-laden droplets. Hence for cell elec-
trospinning these hydrogels were modifi ed with the addition of 
laminin, which increased their viscosity in turn giving rise to 
the formation of an elongating cell laden fi ber(s). In both sce-
narios, several composite cellular samples were collected and 
prepared for (1) cell analysis and (2) animal studies. 
 In these experiments, fl ow cytometry was used to classify cel-
lular populations into four categories (namely: live, early apop-
totic, late apoptotic, and dead), based on the binding of Annexin 
V and/or propidium iodide (PI) to the luciferase-transduced 
murine (IC-21-Luc) macrophages. In the case of apoptotic 
cells, the membrane phospholipid, phosphatidylserine (PS), 
 The techniques of electrospraying and electrospinning have 
existed for at least a century. [ 1,2 ] Both these approaches employ 
a high voltage applied to a needle accommodating the fl ow of 
media, placed above a counter electrode which could either be 
grounded or have an opposite charge to the needle—thus intro-
ducing the charged media to an electric fi eld. Due to the poten-
tial difference between the two electrodes, charged media, on 
entering the electric fi eld, accelerates toward the oppositely 
charged or grounded electrode; depending on the electrode 
setup and the media properties, this results in the formation 
of a stable cone and jet at the needle exit point, with the sub-
sequent formation of either a spray plume of droplets (electro-
spraying) or a continuously elongating thread (electrospinning). 
 Both these approaches have been investigated in many areas 
of research and development, particularly with regard to paint 
sprays, for agricultural applications (through research into aer-
osol sciences), and in the fi ltration industry. [ 3 ] These endeavors 
have demonstrated the wider applicability of these technolo-
gies and hence in the last 20 years or so have been used for 
the direct handling of a wide range of materials, including 
bio-inspired materials. [ 4–6 ] These investigations have gener-
ated much interest in areas such as the development of fi ne 
monolayered surfaces, as well as the fabrication of scaffolds, 
which could be used for many laboratory-based fundamental 
biological studies. [ 7–9 ] Despite numerous publications in the 
literature, architectures generated with these techniques have 
signifi cant technical limitations, which in our opinion have 
restricted their true translation into the biological and medical 
fi elds of research and development. 
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is translocated from the inner to the outer layer of the plasma 
membrane, allowing high affi nity binding of Annexin V. In the 
late stages of cell death, the cell membrane loses integrity and 
becomes leaky to the vital dye PI, thus giving a clear and accu-
rate measurement of the dynamics of cell death. In agreement 
with our extensive previous studies, [ 10–18 ] no detrimental effects 
of bio-electrospraying or cell electrospinning were observed 
over a 72 h period, in comparison with cell culture controls 
(abbreviated to “CC”;  Figure  1 ). 
 IC-21-Luc macrophages (CC or BES) were then incorpo-
rated into a fl uid mixture containing one of three alternative 
rat-tail collagen-based hydrogels, namely, CollaGel Hydrogel, 
CollaGel Hydrogel Soft, or CollaGel Hydrogel Soft+ (resulting 
in six possible combinations of macrophages and biopoly mer), 
prior to subcutaneous injection into the shaved dorsal fl anks 
of C57Bl/6 mice. In vivo bioluminescence was tracked lon-
gitudinally from day 1 to day 4 post-injection using an IVIS 
Lumina II imaging system ( Figure  2 ), as described in the 
Experimental Section. Kinetic analysis of luminescence after 
intraperitoneal injection of  D -luciferin highlighted that a time-
point around 25–30 min was optimal for detecting the plateau 
phase of luminescence ( Figure  3 A). Peak radiance declined 
signifi cantly over the course of the experiment, suggesting 
that IC-21-Luc cells were not retained at the site of implan-
tation. However, no signifi cant differences in peak radiance 
were observed between any of the six experimental groups at a 
given timepoint (Figure  3 B and  Table  1 ). By recombining the 
data, it was apparent that implantation of either CC or BES/
CE macrophages demonstrated a comparable decline in bio-
luminescence over time, when disregarding any effect of the 
biopolymer (Figure  3 C). In contrast, analyzing any effects of 
the biopolymer alone, demonstrated that CollageGel Hydrogel 
maintained a higher peak radiance (particularly at day 3) 
compared with Hydrogel Soft or Hydrogel Soft+ (Figure  3 D). 
These results highlight that subtly different cell/biopolymer 
combinations nevertheless have differing ability to retain 
cells at the site of implantation—which may be due simply 
to the physical nature of the biopolymer, or alterations in the 
microenvironmental response to the biopolymer (including 
local production of cellular growth factors and/or chemoat-
tractants). Such considerations will be the topic of future 
investigations. 
 On day 4 post-injection, the tissue region incorporating the 
implantation site was dissected out and used for histological 
and immunohistochemical analysis. The gelled biopolymer 
was discernable in the subcutaneous region by both standard 
hematoxylin & eosin (H&E) staining ( Figure  4 ) and a modi-
fi ed trichrome (MSB) stain ( Figure  5 ), which labels collagen 
in blue. The MSB staining highlighted the dense, mature col-
lagen in the epidermis (dark blue staining), in contrast to 
the pale blue hydrogel (indicative of less highly cross-linked/
fi brillar collagen). Irrespective of CC, BES/CE, or biopolymer, 
cells with the morphological appearance of macrophages were 
visible surrounding the hydrogel (and also scattered within the 
hydrogel) and extending beneath the muscular layer overlying 
the subcutis. 
 To confi rm the persisting presence of IC-21-Luc macrophages 
at the implantation site, immunohistochemistry using an anti-
luciferase antibody was also performed. Immunostained cells 
were detected in or around the hydrogel ( Figure  6 ), indicating 
that IC-21-Luc macrophages were still localized to this region. 
 These studies together with our previous investigations 
endorse both bio-electrosprays and cell electrospinning as 
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 Figure 1.  Cell viability analysis following bio-electrospraying and cell 
electrospinning. To confi rm the anticipated benign nature of bio-elec-
trospraying and cell electrospinning (as evidenced by extensive previous 
studies), a pilot fl ow cytometric analysis of Annexin V and propidium 
iodide binding was performed on macrophages up to 72 h post bio-elec-
trospraying (BES) or cell electrospinning (CE), versus culture controls 
(CC). No difference in viability was observed between BES, CE, or CC at 
any given timepoint.
 Figure 2.  Bioluminescent imaging of implanted macrophage–biopolymer 
mixes. IC-21-Luc macrophages (CC or BES) were mixed with biopolymer 
(Hydrogel, Soft, or Soft+) and subcutaneously injected into the dorsal 
fl anks of C57Bl/6 mice (three mice per hydrogel, with CC on the left fl ank 
and BES on the right). Following intraperitoneal injection of  D -luciferin, 
macrophage bioluminescence was detected using an IVIS Lumina II 
imaging system. A representative image from day 1 post-implantation 
(and 25 min post luciferin injection) is shown, indicating the peak detect-
able radiance (photons s −1 cm −2 ) in identically sized regions of interest. 
The CE results were very similar to the BES implants.
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versatile platform biotechnologies. They have the capacity to 
directly process living cells in combination with a biopolymer, 
with the addition of either micro and/or nanomaterials for 
simultaneously forming complex living 3D architectures or 
biomaterials for a raft of potential applications in regenerative 
medicine. We and others are currently in the process of elu-
cidating the ability to bio-electrospray or cell electrospin cells 
in a matrix directly into a model organism, so that the tech-
nological implications for direct utilization in the clinic are 
demonstrated. 
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 Figure 3.  Longitudinal bioluminescent image analysis following in vivo macrophage–biopolymer implantation. A) On day 1, a kinetic analysis was 
performed following injection of  D -luciferin to determine the optimal time (≈25 min) for identifi cation of peak radiance (when the rate of change of 
radiance reaches zero), as indicated by an arrow. B) Bioluminescence for each macrophage–biopolymer combination ( n = 3 mice per combination) 
was determined on days 1–4 post-implantation, expressed as a percentage of the peak radiance on day 1. There was a statistically signifi cant decline 
in signal across all groups over time, but not between groups (two-way repeated measures ANOVA with Holm–Sidak post hoc analysis). C) Analysis 
of bioluminescence of CC and BES cells (irrespective of biopolymer) indicated an equivalent statistically signifi cant decline in bioluminescence over 
time. D) Analysis of bioluminescence for the different biopolymers (irrespective of CC/BES) suggests that the standard CollaGel Hydrogel may have 
higher retention of IC-12-Luc bioluminescent signal than Soft or Soft+ (* = p < 0.05 at day 3; two-way repeated measures ANOVA with Holm–Sidak 
post hoc analysis).
 Table 1.  Results of two-way repeated measures ANOVA with Holm–Sidak post hoc analysis, examining effect of factor “Time (days post-implanta-
tion)” within each treatment (i.e., cell–biopolymer combination). 
Comparison CC Hydrogel BES Hydrogel CC Soft BES Soft CC Soft+ BES Soft+
Day 1 versus day 2 ns  p < 0.05  p < 0.05  p < 0.05  p < 0.001  p < 0.05
Day 1 versus day 3  p < 0.05  p < 0.05  p < 0.001  p < 0.001  p < 0.001  p < 0.001
Day 1 versus day 4  p < 0.001  p < 0.001  p < 0.001  p < 0.001  p < 0.001  p < 0.001
Day 2 versus day 3 ns ns  p < 0.05 ns ns ns
Day 2 versus day 4 ns ns ns ns ns  p < 0.05
Day 3 versus day 4 ns ns ns ns ns ns
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 Experimental Section 
 Cell Culture : IC-21-Luc were kindly provided by Dr. Katrina 
McNulty (University College London, London, UK). [ 20 ] IC-21 cells are 
an SV40-transformed peritoneal macrophage cell line derived from the 
C57Bl/6 mouse, and were obtained from the American Type Culture 
Collection. IC-21s stably expressing luciferase were generated by lentiviral 
transduction, using a lentiviral vector plasmid pLenti-CMV-Puro-Luc 
from Dr. E. Campeau, University of Massachusetts Medical School 
(purchased through Addgene Inc., MA, USA; Vector No. 17477). [ 21 ] This 
vector constitutively expresses fi refl y luciferase under the control of a 
CMV promoter, and also has a gene for puromycin resistance. 
 IC-21-Luc cells were grown in RPMI 1640 supplemented with 10% 
(v/v) fetal bovine serum (FBS),  L -glutamine (2 × 10 −3  M ), and antibiotics 
(50 IU mL −1 penicillin and 50 µg mL −1 streptomycin; all from Life 
Technologies, UK), at 37 °C/5% CO 2 in a humidifi ed atmosphere. 
Cells were passaged using nonenzymatic cell dissociation buffer (Life 
Technologies, UK), according to the manufacturer’s recommendations. 
IC21-Luc cells were grown in media containing 2 µg mL −1 puromycin for 
at least one week during expansion to select for luciferase-transduced 
cells. Harvested macrophages were initially split into three equal 
aliquots: (1) untreated CC, (2) cells subsequently subjected to BES, and 
(3) cells subsequently exposed to CE. 
 Bio-Electrospraying and Cell Electrospinning : Cells were handled 
using either a single needle bio-electrospray setup or a coaxial cell 
electrospinning needle system. Both these needle systems have 
previously been described elsewhere. [ 10a  ,  12 ] Briefl y, the single needle 
bio-electrospray setup had an internal bore diameter of ≈800 µm with 
a wall thickness of ≈700 µm with the ground electrode placed ≈10 mm 
below the needle thus giving rise to an electric fi eld between 0.5 and 
1.5 kV mm −1 over an applied voltage range of 5–15 kV. The coaxial cell 
electrospinning needle explored in these studies had an inner bore 
diameter of the inner needle of ≈700 µm with a wall thickness of ≈700 µm 
while the outer needle had an inner bore diameter of 1900 µm with a 
wall thickness of ≈800 µm. During these cell electrospinning studies a 
grounded mesh electrode was maintained at a distance of about 15 mm 
below the needle system, giving rise to an electric fi eld ranging from 
0.33 to 0.66 kV mm −1 for an applied voltage range from 5 to 10 kV. Both 
systems were housed in a class II laminar fl ow hood to maintain sterility. 
 Flow Cytometry Assessment of Cell Viability : Flow cytometry was used 
to assess the viability of post-BES/CE cells in comparison to controls 
(CC). Cells were collected at 0, 24, 48, and 72 h after bio-electrospraying 
or cell electrospinning and incubated at room temperature for ≈15 min 
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 Figure 4.  Histological analysis of the macrophage–biopolymer implanta-
tion site (H&E staining). At day 4 post-implantation, skin was harvested 
from each dorsal fl ank, and processed for histology. The various hydro-
gels (indicated by *) were discernible within the subcutis. Cells with the 
morphological appearance of macrophages were visible surrounding the 
hydrogel, with a scattering of cells within the hydrogel. Scale bar: 200 µm.
 Figure 5.  Histological analysis of the macrophage–biopolymer implanta-
tion site (MSB staining). At day 4 post-implantation, skin was harvested 
from each dorsal fl ank, and processed for histology. Where possible, serial 
sections directly adjacent to those shown in Figure  4 were stained with 
a modifi ed trichrome stain. Mature fi brillar collagen within the dermis 
appeared dark blue, while the collagen within the hydrogel was generally 
lighter blue in appearance, indicating a less highly cross-linked or fi brillar 
form of collagen. Scale bar: 200 µm.
 Figure 6.  Immunolocalization of IC-21-Luc macrophages at the skin 
implantation site. Immunohistochemistry with an anti-luciferase antibody 
was used to verify whether cells within or surrounding the hydrogel were 
IC-21-Luc macrophages expressing this gene. The presence of luciferase 
immunolocalized (brown staining) to the intracellular compartment of 
cells with the morphological appearance of macrophages, in the same 
subcutaneous region as the hydrogel. Scale bar: 50 µm.
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in Annexin V buffer containing 1.8 × 10 −3  M calcium, 4 µL mL −1 FITC-
labeled Annexin V (Pharmingen, UK), and 5 µg mL −1 PI (Sigma, UK). 
Annexin V and PI stain those cells undergoing apoptosis/cell death, 
by binding to phosphatidylserine in the cell membrane, or to cellular 
DNA, respectively—and this binding can be visualized by way of fl ow 
cytometry. Thus, labeled samples were immediately analyzed using fl ow 
cytometry (Becton Dickinson LSR II; BD Biosciences, Oxford, UK), with 
>20 000 events collected for each sample. In parallel, unlabelled cells 
at these time points were morphologically examined by standard phase 
contrast light microscopy (Leica MZ10, Leica Microsystems, UK). 
 Biopolymers Used in These Studies : Three different rat-tail collagen-
based hydrogels were investigated in these studies. These hydrogels 
were provided by Olaf Pharmaceuticals. They were (a) CollaGel Hydrogel, 
(b) CollaGel Hydrogel Soft, and (c) CollaGel Hydrogel Soft+. CollaGel 
Hydrogel Soft contains a less rigid and more porous matrix than regular 
Collagel Hydrogel and Soft + contains additives for enhanced growth 
and attachment. All three of these hydrogels are a biocompatible 
complex of Type I Collagen fi bers. These hydrogels contain a high quality, 
sterile Type I Rat Tendon Collagen that has been specially formulated 
for ease of gel formation. A useful feature for the current studies is that 
these gels both could be made to free fl ow and also gels once injected 
into mice. Additionally, the gels have a reasonable ability to withstand 
stretching without tearing. For cell electrospinning studies these gels 
were further modifi ed by mixing in concentrated laminin to increase their 
viscoelasticity so that they could be cell electrospun in stable conditions. 
 Bioluminescent Imaging of Mice : Male C57BL/6J mice (Charles River, 
UK) were housed in a specifi c pathogen-free facility, and all procedures 
were performed on mice between 12 and 15 weeks of age ( n = 3 per 
group). All animal studies were ethically approved and licensed under 
the UK Home Offi ce Animals (Scientifi c Procedures) Act 1986. Under 
light isofl urane-induced anesthesia, the dorsal fl anks of each mouse 
were shaved and sterilized. 3 × 10 6 untreated IC21-Luc cells (CC) or 
those subjected to BES or CE were mixed 1:1 (v/v) with the respective 
biopolymers: (a) CollaGel Hydrogel, (b) CollaGel Hydrogel Soft, or 
(c) CollaGel Hydrogel Soft+. A total volume of 100 µL of the particular 
hydrogel/cell mix was then injected subcutaneously into the dorsal fl ank 
(with CC on the left side and BES on the right side of each mouse), and 
allowed to gel. 
 On days 1–4 post-injection, 150 µL of  D -luciferin substrate 
(10 mg mL −1 ; Regis Technologies Inc., USA) was given by intraperitoneal 
injection prior to imaging. For imaging, mice were anesthetized in an 
induction chamber using isofl urane and then transferred to the imaging 
chamber of an IVIS Lumina II imaging system (Caliper Life Sciences, UK) 
where they were maintained on isofl urane anesthesia via nose cones, and 
kept on a heated mat to maintain body temperature. On each of days 1–4 
post-injection, luminescent images were acquired with an exposure time 
of 5 min, 24 × 24 cm fi eld of view, medium binning (factor 4), and  f stop 
1.2, starting from 15 min after the luciferin injection, to enable empirical 
determination of imaging during the plateau phase of bioluminescence. 
 Bioluminescent Image Analysis : Images were analyzed using Living 
Image 3.2 software (Caliper Life Sciences, UK) to generate pseudo-color 
scaled images overlaid on greyscale images, providing 2D localization 
of the luminescent light source. Identically sized 2.0 × 1.3 cm regions 
of interest (ROI) were drawn using shape tools and the light emission 
(peak radiance) within each ROI (placed above the left and right dorsal 
fl ank) was quantifi ed in photons per second, during the plateau phase of 
bioluminescence. 
 Tissue Harvesting, Histological and Immunohistochemical Analysis : 
Animals were sacrifi ced 4 d following cell transfer, and skin 
encompassing the transfer site was dissected out, fi xed in 4% 
paraformaldehyde for 24 h, and then dehydrated through ethanol prior 
to embedding in a transverse orientation in paraffi n wax. For subsequent 
analysis, 2–5 µm sections were then cut and stained with standard H&E 
staining, or a modifi ed trichrome (Martius Scarlet Blue [MSB]) stain 
for collagen, using an automated Sakura Tissue-Tek DRS 2000 Multiple 
Slide Stainer. 
 For luciferase immunohistochemistry, sections were dewaxed, 
antigens retrieved using standard citrate treatment, washed and then 
incubated with 3% hydrogen peroxide for 30 min to block endogenous 
peroxidase activity. Sections were blocked with a solution of 1:6 (v/v) 
goat serum in TBS with avidin block (Avidin/Biotin Blocking Kit, 
Vector Laboratories, Burlingame, USA) for 20 min, and then incubated 
overnight at 4 °C with a rabbit polyclonal anti-fi refl y luciferase antibody 
(1:2000 dilution; Abcam, UK) in TBS with 1% BSA, 1% goat serum, and 
biotin block (Avidin/Biotin Blocking Kit, Vector Laboratories, Burlingame, 
USA). After washing, sections were incubated for 1 h with biotinylated 
goat anti-rabbit IgG (diluted 1:200 in TBS with 1% BSA). After three 
further washes, sections were incubated for 30 min with streptavidin-
conjugated horseradish peroxidase (Invitrogen, Paisley, UK) diluted 
1:200 in TBS. Sections were washed and incubated with DAB Peroxidase 
Substrate Kit (Vector Labs, Burlingame, USA) for 10 min, followed by 
counterstaining with Gill-2 hematoxylin (Thermo Shandon, USA). 
 All sections were subsequently scanned on a Nanozoomer and 
images were captured using NDP view software (both from Hamamatsu 
Corporation, Hamamatsu, Japan). 
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